Replies to post #132552 on Biotech Values

[ghmm]

FDA also removed black box restrictions for Promacta

http://www.fda.gov/Drugs/DrugSafety/ucm280165.htm

It may take a little bit but I am in the camp that boosting platelet is gong to be a very meaningful market opportunity. Promacta has a few things going for it along with being oral GSK has initiated a ton of studies. I am just hoping they pursue development of one of the followon molecules which has a higher royalty.